TMO On Other Exchanges
New York
Sao Paulo
text size: T | T
Back to Snapshot
Company Description

Contact Info

81 Wyman Street

Waltham, MA 02451

United States

Phone: 781-622-1000


e portfolio includes antibodies and products for protein purification, detection, modification, and analysis; and sequencing, detection and purification products used for high content analysis of nucleic acids. Many of these products are also used in applied markets, including agriculture, forensics, diagnostics product development, and toxicology research. Tools used for genetic engineering, amplification, quantification and analysis, as well as RNA isolation, including stem cell reprogramming kits, transfection reagents, RNA interference reagents, along with gene editing tools and gene synthesis products. Cell culture media and reagents for preserving and growing mammalian cells, which are used in many life science research applications. Fluorescence-based technologies, which facilitate the labeling of molecules for biological research and drug discovery. These technologies include a range of cell analysis instruments, including flow cytometers and imaging platforms that enable fluorescence microscopy. Protein analysis products, including pre-cast electrophoresis gels for separating nucleic acids and proteins, and western blotting and staining tools. Genetic Sciences and Next-Generation Sequencing The company’s genetic, medical and applied sciences business combines various instruments and related reagents used to analyze DNA across a range of applications in research, clinical and applied markets. The company’s genetic, medical and applied sciences offerings comprise: Capillary electrophoresis (CE), quantitative PCR, and Next Generation Sequencing (NGS) platforms and reagents. These products are used to discover sources of genetic and epigenetic variation, to catalog the DNA structure of organisms, and to verify the composition of genetic research material. In addition to research, these genetic analysis techniques are used in various applied markets, including human identification (HID), animal health and food safety. In HID, the company provides its instrument platforms and reagents to forensic laboratories that analyze DNA recovered from crime scenes. Primary customers include the FBI and police departments worldwide. The company’s technologies are also used in various clinical research and diagnostic applications with a focus on cancer and inherited disease. These applications include molecular diagnostics, diagnostic development, clinical and translational research, and public health monitoring. PCR and real-time PCR systems, reagents and assays that enable researchers to amplify and detect targeted nucleic acids (DNA and RNA molecules) for a host of applications in molecular biology. BioProduction The company’s bioproduction business supports developers and manufacturers of biological-based therapeutics and vaccines with a portfolio of premium solutions and services focused on upstream cell culture, downstream purification, analytics for detection and quantitation of process/product impurities, and a suite of single-use solutions spanning the biologics workflow. The company’s bioproduction offerings comprise: Single-use bioproduction solutions that provide the company’s customers with faster turnaround and set-up times, minimal validation requirements, reduced investment and running costs, and increased flexibility of manufacturing capacity. Production cell culture media solutions, which are used by major biotechnology and pharmaceutical companies to grow cells in controlled conditions and enable large scale Current Good Manufacturing Processes manufacturing of drugs and vaccines. The company also provides its customers with the associated services to optimize the productivity of these production platforms. Chromatography products, which deliver unmatched capacity and resolution for process-scale bioseparations, and offer a set of scalable options for the purification of antibodies, antibody fragments and proteins. Rapid molecular products that deliver accurate results in approximately four hours for contaminant detection, identification and quantitation. Solutions for the manufacture of cell therapy based drugs. Analytical Instruments segment This segment provid


The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

TMO Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TMO.
View Industry Companies

Industry Analysis


Industry Average

Valuation TMO Industry Range
Price/Earnings 30.3x
Price/Sales 3.4x
Price/Book 2.8x
Price/Cash Flow 29.9x
TEV/Sales 2.6x

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact THERMO FISHER SCIENTIFIC INC, please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at